Five Star Stock

After trending lower for the last couple of months, Sarepta Therapeutics surged 39.3 percent after announcing plans to file for a new drug application (NDA) for their lead drug eteplirsen later this year. You see, Sarepta had been told last year by the Food and Drug Administration (FDA) that...

While certain industries such as biotech and internet stocks have experienced some strong selling lately, other industries and sectors have held up quite well. The second best performing sector over the last 30 days has been the financials, second only to utilities. Obviously it never hurts to...

Wendy's released earnings Monday and apparently the market likes the preztel bun as much as consumers, which is understandable. In response, the stock jumped over six percent on more than five times its normal volume. Unfortunately, if you weren't already in the stock, your cheese was left...

For historical reference, check out this post on Facebook from November 18. Shares have risen nicely lately, but like its counterpart Twitter, it has been rough the past couple of days. Now the question is: Where might the selling of Facebook stop?  Related: Five Star Stock Watch: Twitter...

When it comes to bank stocks, it doesn't get much bigger than Bank of America. The stock trades almost 100 million shares per day, on average. To compare, JP Morgan's stock trades an average of 19 million shares a day. So, there is a strong interest in the performance of Bank of America's...

Zillow's rise from $25 earlier this year to north of $100 back in September was tremendous, to say the least. However, the last several months have not been as kind. After dropping by as much as 30 percent since that $100 peak, has Zillow's slide possibly come to an end? Judging from the...

After rallying quite nicely over the last 3 months, Microsoft's stock dropped every day last week, falling from a high near $39 down to just below $36. Investors are probably wondering when the slide will end, while others might be wondering when its time to buy. Judging from Microsoft's stock...

Of the 28 analysts following Priceline.com's stock, 20 of them have it rated as a "buy." The median price target is $1210, while the stock is currently trading near $1200. So, with the price of the stock having reached the median analyst target, is Priceline.com still a buy? If you don't...